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Abstract
Most adult tissues consist of stem cells, progenitors, and mature cells, and this hierarchical architecture may play
an important role in the multistep process of carcinogenesis. Here, we develop and discuss the important predic-
tions of a simple mathematical model of cancer initiation and early progression within a hierarchically structured
tissue. This work presents a model that incorporates both the sequential acquisition of phenotype altering muta-
tions and tissue hierarchy. The model simulates the progressive effect of accumulating mutations that lead to an in-
crease in fitness or the induction of genetic instability. A novel aspect of the model is that symmetric self-renewal,
asymmetric division, and differentiation are all incorporated, and this enables the quantitative study of the effect of
mutations that deregulate the normal, homeostatic stem cell division pattern. The model is also capable of pre-
dicting changes in both tissue composition and in the progression of cells along their lineage at any given time and
for various sequences of mutations. Simulations predict that the specific order in which mutations are acquired is
crucial for determining the pace of cancer development. Interestingly, we find that the importance of genetic sta-
bility differs significantly depending on the physiological expression of mutations related to symmetric self-renewal
and differentiation of stem and progenitor cells. In particular, mutations that lead to the alteration of the stem cell
division pattern or the acquisition of some degree of immortality in committed progenitors lead to an early onset of
cancer and diminish the impact of genetic instability.
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Introduction
It is widely accepted that tumorigenesis is a multistep process, the
progression of which depends on a sequential accumulation of mu-
tations within tissue cells. Although tumor cells often exhibit a large
number of mutations [1,2], only a relatively small subset is crucial for
neoplastic development [2–6]. These mutations result in violation of
tissue homeostasis as the transformed cells gain fitness by increasing
their proliferation rate, decreasing their death rate, and creating a
growth-promoting environment. The variety of genetic alterations
observed in tumors suggests that genetic instability is a characteristic
of many cancers [7,8]. The process of acquiring genetic mutations
and the role of genetic instability in tumorigenesis have received a
great deal of attention in the cancer modeling community and have
been studied using both deterministic and stochastic approaches [9–
25]. Spencer et al. [16], for example, used a deterministic model to
study carcinogenesis within a homogeneous population of cells. They
predicted that the pace of cancer development depends on the par-
ticular ordering of mutations and that the fastest pathways to cancer
were those for which genetic instability was the last mutation ac-
quired. Conversely, Beckman and Loeb [20], who also used a deter-
ministic mathematical model to calculate the probabilities of cancer
occurrence for pathways that did or did not include mutator muta-
tions, found that these types of mutations have the most influence
when they occur as an initial step in carcinogenesis. The relative
importance of processes such as selection and clonal expansion versus
genetic instability has been addressed in numerous modeling stud-
ies, mostly in the context of colorectal carcinogenesis. Some of the
models, both deterministic and stochastic, have lead to the con-
clusion that genetic instability is not necessary to explain the large
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number of mutations found in tumors [21,24], whereas others no-
ticed the importance of genomic instability as a driver of cancer
formation [22,23].
Experimental evidence shows that only a small fraction of tumor
cells are actually capable of tumor initiation [26–28]. Studies suggest
that cancers originate from stem cells or cells that have gained stem
cell properties. These tumorigenic cells, cancer stem cells, are believed
to be the driving force in tumor progression and a possible cause of
tumor heterogeneity [26,27]. Adult stem cells are present in many
tissues, and although their number is relatively small, they persist
for long periods, in some cases, throughout the entire lifetime of
an individual. Given that carcinogenesis requires acquisition of mul-
tiple mutations during a long period, stem cells are reasonable can-
didates for the accumulation of mutations that results in a malignant
transformation. In addition to their long life span, stem cells are able
to generate full lineages of differentiated cells, thereby perpetuating
mutations through uncontrolled clonal expansion. Since the identi-
fication of cancer stem cells in hematopoietic malignancies [29,30],
cancer stem cells have been found in a variety of cancers [31–36]. It
is believed that cancer stem cells may arise from mutations in nor-
mal stem cells, or in some cases, such as blast crisis associated with
chronic myeloid leukemia (CML) [37], mutations might cause re-
stricted progenitors to acquire properties of cancer stem cells, partic-
ularly the ability to limitlessly self-renew, leading to a rapid outbreak
of aggressive cellular growth.
The cancer stem cell hypothesis has enormous implications for
cancer therapeutics. Current treatments target the rapidly dividing
differentiating cells that comprise the major bulk of tumors, often
leading to significant reduction in tumor size. However, even if treat-
ment seems successful, a single cancer stem cell that survives therapy
may drive tumor recurrence [38]. Being a crucial factor in designing
successful treatment, the need to understand the deregulated mech-
anisms that alter the homeostatic pattern of divisions in stem cells is
a strong motivation to include cellular hierarchy in computational
models of tumorigenesis.
Numerous modeling studies have considered hierarchical tissue ar-
chitecture in the context of cancer development [39–48]. It has been
shown that hierarchical tissue design, in which a small population of
stem cells maintains mature cells through a transient population of
differentiating cells, may reduce the accumulation of hazardous mu-
tations [39–42]. In addition, certain aspects of the cancer stem cell
hypothesis have been addressed using both stochastic and determin-
istic approaches. For example, Dingli et al. [44] used a stochastic
model to study evolutionary paths of cancer stem cells and demon-
strated that stochastic effects within a small population of cycling
stem cells may influence the dynamics of cancer evolution in differ-
ent manners by inducing a wide variability in the dynamics of the
mutated clone. Ganguly and Puri [45] proposed a predictive, multi-
compartment model to study the effect of the cancer stem cell hy-
pothesis in the neural system. Their model verifies that the mutations
in the stem cell compartment are more significant for cancer devel-
opment; however, similarly to Dingli’s stochastic model, only normal
and cancerous cells are considered, without including any intermedi-
ate stage cellular mutations; therefore, the progressive phenotypical
changes in cells owing to sequentially acquired mutations and their
associated dynamics are not discussed.
The various models of cancer development that have appeared in
the literature so far have led to a deeper understanding of the differ-
ent biological aspects of tumorigenesis by focusing on a particular
aspect of tumor growth. Some have modeled carcinogenesis as a mul-
tistep process of mutation acquisition within a homogeneous cell
population, others studied the consequence of hierarchy in tissues;
however, to our knowledge, the sequential acquisition of phenotype
altering mutations in hierarchical population of cells has only been
considered in few works, such as that of Bankhead et al. [47] who
have used a computational model based on the Genetic Cellular
Automata to compare genetic heterogeneity of mutated populations
of cells assuming different internal hierarchies. In the present work,
we consider the simplest hierarchy to study propagation of somatic
mutations in stem cells and progenitors and their effect on the pace
of carcinogenesis. We propose a simple mathematical framework that
brings together the various aspects of the current understanding of
tumorigenesis into a comprehensive model that accounts for the de-
velopment and dynamics of transformed cells. The basic model may
be extended to include different phenotypic alterations in cells as well
as intercellular population and cell-environment interactions. An ex-
ample of one possible extension for the case of immortal progenitors
is discussed in this paper.
This work marks the first time that all possible modes of stem cell
divisions (Figure 1B), symmetric and asymmetric [47], have been in-
cluded and dynamically modeled. This enables a quantitative study
(within the limits of model assumptions) of the deregulation of stem
cell division modes and its potential to result in neoplastic growth.
We note that Dingli et al. [46] studied the impact of various stem
cell division modes on the growth dynamics of a mutant stem cell
population; however, they assumed that the stem cell pool remains
constant in size and used a stochastic Moran process to describe the
dynamics of the stem cell pool (comprised of normal and mutated
stem cells). Although capturing the stochastic nature of mutation
acquisition, this type of model is not capable of describing mutations
that lead to the change of stem cell division pattern that results
in possible expansion of the stem cell pool, which in turn leads to
tumor growth.
Figure 1. The model’s basic components. (A) Mutations: Schematic
view of the multistep process of mutation acquisition. (B) Stem cell
division modes: symmetric self-renewal division results in two
daughter stem cells, asymmetric self-renewal division results in
one stem cell and one progenitor cell, and symmetric differentiation
division results in two progenitor cells.
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In this article, we consider the multistage process of mutation ac-
quisition within a tissue comprised of stem cells that give rise to pro-
genitor cells, which in turn divide and differentiate into mature
functioning cells. We assume that all cells divide at the same average
rate and do not include explicitly quiescent stem cells [48]. We only
consider somatic mutations and, at the present model, ignore envi-
ronmental effects [49–51]. In particular, we assume that the dereg-
ulation of stem cell division occurs because of a somatic mutation
in stem cells rather than because of environmental changes. In our
model, the change in the division pattern of mutated stem cells
may be a direct result of a mutated division mechanism or may be
caused by ignored environmental signaling. Using a simple mathe-
matical model, we explore the effects of a variety of somatic muta-
tions in stem cells and their progeny. In particular, we address some
of the very different findings regarding genetic instability that have
appeared in the literature. The model is general enough to study
both advantageous and deleterious mutations. Within the proposed
framework, we have incorporated mutations that affect prolifera-
tion, death, and mutation rates as well as division and differentiation
patterns. Therefore, we have been able to explore the effects of dif-
ferences in the order in which mutations are accumulated and to
quantify their influence on both the pace toward cancer and on tem-
poral changes in tissue composition during cancer development. We
have shown that the cancer stem cell hypothesis arises as a natural
consequence of the hierarchical structure of the model, and there-
fore, the model can be used to test its implications. In addition,
we have investigated the effect of mutations that deregulate the divi-
sion pattern in stem cells or lead to some degree of immortality in
progenitor cells, both of which may be crucial for the development of
aggressive cancers.
The rest of the paper is organized in three main sections. In the
Materials and Methods section, we introduce the compartmental
model for a normal tissue and then extend it to include mutations.
The complete set of the basic model equations can be found in the
Supplemental Material. Simulation results are presented in the Re-
sults section, each subsection of which focus on a different aspect
of the model or its extension. In the Pathways to Cancer subsection,
we consider the effect of various sequences of mutations that alter cell
phenotype according to the Mutated A column in Table 1. In the
Tissue Composition subsection, we point out the differences in re-
sulting tissue composition for the different mutation sequences. The
results of three alterations of the basic model are discussed in the last
three subsections where we consider mutations that affect the divi-
sion pattern of stem cells (Mutated B column in Table 1), mutations
that lead to immortality of progenitors, and a mechanism that de-
creases survival of mutated cells. In the last section, these results
are discussed, and some possible future extensions are suggested.
The equations for the altered models and a demonstration of the com-
patibility of the model with the cancer stem cell hypothesis are given
in the Supplemental Material.
Materials and Methods
Here, a mathematical framework is developed to study carcinogen-
esis as a multistep process evolving within normal tissue. The tissue is
modeled compartmentally by a system of ordinary differential equa-
tions that describe the coexisting cell populations with an underlying
hierarchy. The cell populations differ in their proliferation potential,
division, and death rates and ultimately play very different roles in
cancer development.
Model for Normal Tissue
Three main types of cells constitute the normal tissue: stem cells,
progenitor cells, and mature, functioning tissue cells (Figure 2A).
Stem cells are characterized by their ability to self-renew and to dif-
ferentiate into all cell types that are found in a specific tissue. These
long-lived cells have limitless proliferation potential and can undergo
three types of division [52] (Figure 1B). Symmetric renewal results in
Table 1. Parameters Used for Simulations.
Normal Mutated (A) Mutated (B) Mutated (C) Mutated (D)
Stem cells
Rate of division (per day) [59,66] 0.0115 0.0207 0.0115 0.0207 0.0207
Percentage of asymmetrically self-renewing stem cells 80% 80% 60% 80% 80%
Percentage of symmetrically self-renewing stem cells 10% 10% 30% 10% 10%
Percentage of symmetrically differentiating stem cells 10% 10% 10% 10% 10%
Rate of death (per day) [66] 0.0001 0.00006 0.00006 0.00006 0.00006
Rate of death if protection mechanism is included (per day) NA NA NA NA 0.1
Rate of mutations* [8,16,67,68] 0.00001 0.001 0.001 0.001 0.001
Number of stem cells [61,69] 900,000
Differentiating cells
Number of progenitor divisions [61] 28 28 28 28† 28
Probability of immortality for progenitors with immortality mutation NA NA NA 0.000001 NA
Division rate in progenitors (per day) 0.5 3.6 3.6 3.6 3.6
Death rate in progenitors (per day) 0.001 0.0006 0.0006 0.0006 0.0006
Rate of death if protection mechanism is included (per day) NA NA NA NA 0.1
Death rate in mature cells (per day) 1 0.6 0.6 0.6 0.6
Rate of mutations [8,16,67,68] 0.00001 0.001 0.001 0.001 0.001
Number of mature cells [61,66] 9 × 1011
The parameters listed here have been used in the numerical simulations of the model equations. These parameters are taken mainly from the hematopoietic system because the parameters for other tissues
are significantly less known. The mutated rates are shown for four cases: (A) refers to the case where R-mutation increases division rate; (B) refers to the case where R-mutation leaves proliferation rate
unchanged but alters the pattern of division in stem cells while increasing proliferation rate in progenitors; (C) refers to the scenario discussed in the Immortality of Progenitors subsection; (D) refers to
the case discussed in the Protection Mechanism subsection.
*The mutation rate, i.e., the probability of a mutation to occur in a gene during cell division, is estimated in the literature to be 10−8 to 10−6. Because we are interested in the probability of occurrence of a
mutation in one of the physiological gene categories, assuming that each is a group of approximately 100 genes, we multiply the rate for individual gene by 100. Therefore, in our simulations, we use the
mutation rate of 10−5.
†This number of division refers to the non–self-renewing progenitors that have not acquired the immortality mutation.
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two daughter stem cells, asymmetric division results in one stem cell
and one progenitor cell, leaving the number of stem cells unchanged,
and symmetric differentiation gives rise to two progenitor cells. The
net rate of change in the number of stem cells is determined by com-
bining the rates of symmetric renewal, symmetric differentiation, and
death (Eq. 1).
Asymmetric division maintains a constant number of stem cells
and is believed to be dominant in normal tissue homeostasis [51–
55]; however, no solid evidence exists to support a preference of
asymmetric over symmetric modes of division [52]. Furthermore,
data suggest that most stem cells are able to switch between the dif-
ferent modes of division, depending on internal and external cues
[51], so that the balance of stem cell numbers may be maintained
by a variety of division scenarios [52]. This evidence provides strong
motivation for the inclusion of all three mechanisms of division in
our model. Note, however, that asymmetric division does not affect
the number of stem cells and therefore does not contribute to Eq. 1.
Stem cells give rise to progenitor cells that undergo a limited num-
ber of mitotic divisions, producing the complete progeny of mature
functioning cells for a particular tissue. Unlike stem cells, the popu-
lation of differentiating cells goes through a maturation process, grad-
ually losing their proliferative potential as they divide and progress
toward their final fate [56]. These cells continue dividing until full
differentiation is achieved; they remain in the tissue for a certain pe-
riod to perform their specific function before undergoing apoptosis.
Our model simulates the process of maturation of the differentiating
progenitors as it occurs biologically, through division, by a set of N +
1 ordinary differential equations, where N is the maximal number of
cell divisions for progenitors in the specific tissue. Each equation is a
statement of balance for the number of cells in a particular genera-
tion. The number of divisions and the time required for the entire
Figure 2. Schematic representation of the mathematical model: (A) Normal tissue: stem cells self-renew and differentiate into progenitors
thatmaturewith each division until they become totally differentiated cells, lose their ability to proliferate, and die. (B)Mutation acquisition:
mutations accumulate in tissue cells and are inherited by progeny (Eqs. S6–9 in the Supplemental Material).
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process starting from a division of a stem cell until terminal differen-
tiation vary with tissue type.
The number of the earliest progenitors is increased owing to the
addition of the newly born progenitors resulting from asymmetric di-
vision and symmetric differentiation in stem cells. Whereas stem cell
divisions increase this population, its size is reduced owing to pro-
genitor division (the resulting daughter cells contribute to the next
generation of progenitors) and death in this compartment. These
processes are summarized in Eq. 2. Notice that each asymmetric di-
vision contributes one progenitor, whereas symmetric differentiation
division contributes two.
The subsequent generations (N − 1) of transient progenitor cells
are described by Eq. 3. Each generation of progenitors is increased
by dividing cells in the preceding generation and decreases in size
through division of its constituent cells. For any generation labeled
n between 1 and N − 1, we can write:
Lastly, following similar reasoning, the rate of change in the num-
ber of fully mature, nonproliferating cells is given in Eq. 4.
For appropriate rates of proliferation and death, Eqs. 1–4 lead to
homeostatic dynamics, that is, a steady state of a healthy tissue. The
exact mathematical formulation of the above balance statements, to-
gether with the steady state solution, is given in Supplemental Ma-
terial (Eqs. S1–5).
Model for Mutation Acquisition
We now extend the model of normal tissue homeostasis to include
the process of mutation acquisition. Somatic mutations that occur in
the DNA of individual cells at some time during a person’s lifetime
are considered. Although these changes can be caused by environ-
mental factors such as ultraviolet radiation from the sun, we restrict
our attention to those that occur when a mistake is made as DNA
copies itself during cell division. Our model follows the paradigm of
Hanahan and Weinberg [57], who suggest that a common feature in
all cancers is that only a small number of mutations in the cell’s phys-
iology are needed for cancer to develop. Whereas these authors sug-
gested that there are six categories of changes in cellular physiology
that lead to malignancy, we consider only three, because our interest
is in the pathways that initiate cancerous growth rather than in can-
cer progression, invasion, and metastasis.
We restrict consideration to the following classes of somatic muta-
tions which are involved in tumorigenesis: 1) R-mutation (R) repre-
sents either a gain of function mutation in a proto-oncogene that
causes the inappropriate or excess expression of proteins that control
cell proliferation or a loss of function mutation to a tumor-suppressor
gene that controls cell cycle checkpoints or regulates the secretion of
receptor hormones that inhibit cell proliferation. Ultimately, the R-
mutation leads to the deregulation of the cellular proliferation, either
owing to self-sufficiency in growth signals or to insensitivity to anti-
growth signals, resulting in a net increase of the replication rate or a
shift in the balance of stem cell division modes. 2)D-mutation (D) rep-
resents a loss of function mutation to a tumor-suppressor gene that
mediates the synthesis of proteins that promote apoptosis. This mu-
tation decreases the death rate of cells and may also be associated with
the acquisition of extensive (or even limitless) replication potential by
the mutated cells during their extended life span. 3) G-mutation (G )
stands for genomic instability, which increases the cellular mutation
rate. This last mutation is considered by Hanahan and Weinberg
[57] as an enabling tool to acquire enough mutations that cause ma-
lignancy to develop during human lifetime. These three categories of
mutations are believed to be sufficient for the description of early stage
of tumor initiation. As our focus is on the dynamics of carcinogenesis,
that is, in the period before the onset of angiogenesis, mutations asso-
ciated with the angiogenic switch are not considered. These mutations
become relevant at later stages of tumor development, after the tumor
has reached the diffusion limit [58]. We also do not discuss tissue in-
vasion and metastases, which are relevant in later stages of the disease.
Our mathematical formulation rests on the assumption that the
multistep transformation that mediates the transition of cells from
a normal to a cancerous state requires the presence of all three muta-
tions, D, R, and G (Figure 1A). Biological evidence suggests that
tumors exhibit a cellular hierarchy similar to that of normal tissue,
and this hierarchical structure of the mutated populations occurs
naturally in our model. The inclusion of mutations into the model
Eqs. S1–4 not only changes the dynamics of normal tissue but also
adds mutated populations of stem, progenitor, and mature cells, as
illustrated in Figure 2B. As cells acquire mutations, they move to
a population with a higher number of mutations, until they reach
the population with three mutations and stay there, as they become,
according to our definitions, cancerous cells (Figure 2B, rightmost
column). The populations considered in the model vary by cell type,
number of divisions, and number of acquired mutations. The dy-
namics of each population can be studied separately or collectively,
depending on the question of interest. The complete set of equations
that describes the normal and the mutated populations is constructed
following the reasoning used for normal tissue modeling and is given
in detail in Supplemental Material, Eqs. S6–9.
Model Parameters
Using the model to simulate cancer initiation in specific tissues re-
quires the knowledge of the various parameter values associated with
the particular tissue of interest. Cells within different tissues show ev-
idence of significantly different rates of proliferation and death and dif-
ferent numbers of divisions along the lineages that take a cell from a
stem cell all the way to maturation. These differences lead to the spe-
cialized tissue dynamics that are attributed to the variety of tissues in
the body. For example, whereas hematopoietic stem cells are believed
to divide on average every 23 to 67 weeks [59], colonic crypt stem cells
divide much more frequently, approximately once in every 10 days
[60], on average. The number of divisions required to reach matura-
tion also differs between those two tissues. Whereas 20 to 30 divisions
are estimated for hematopoietic progenitors [61], colonic crypt pro-
genitors complete only 4 to 6 divisions [60] as they climb up the crypt
on their way to becoming mature functioning cells. Unfortunately,
many of the parameter values associated with the model have not been
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experimentally determined for most tissues. We therefore simulated
the model using a wide range of parameters; however, we present re-
sults for parameters related to the well-studied hematopoietic system
(Table 1). Even in that case, many parameters are allusive, for example,
we had to adjust the number of stem cells (9 × 105 cells) so that for a
chosen division rate of stem cells (0.016 divisions per day) and progeni-
tors (0.5 divisions per day) and for a chosen number of progenitor gen-
erations (28 generations), the homeostatic number of mature cells
(estimated as 1012 cells) will be maintained.
Table 1 contains parameters that correspond to the different sce-
narios discussed in the text. The column named Normal presents the
parameters used to simulate normal, homeostatic tissue. Deviations
from homeostasis that occur as a result of acquiring a certain muta-
tion are presented in the four columns named Mutated (A)–Mutated
(D), each corresponds to the different scenarios described in the Re-
sults section. Notice that in the absence of mutations, the value from
column Normal has to be used. For example, stem cells that have
acquired only the R-mutation in scenario referred to as Mutated
(A) will exhibit increased rate of division—as is indicated in the ap-
propriate entry in column Mutated (A), whereas the rates of death
and mutation will remain normal (the values taken from the column
Normal). Notice that in this case, the proportion of stem cell under-
going symmetric and asymmetric divisions does not change. Alterna-
tively, stem cells that have acquired only the R-mutation in scenario
referred to as Mutated (B) will divide at a normal rate, but the propor-
tions of the symmetric and asymmetric modes of division will
be changed according to columnMutated (B). The rates of division and
mutation of these cells will remain normal (the values taken from col-
umn Normal). Progenitor cells that have acquired all three mutations
in scenario referred to as Mutated (A) will exhibit changes in rates of
division, death, and mutation, as indicated in column Mutated (A).
Results
The mathematical model was numerically simulated using the pa-
rameter values listed in Table 1. Consistent with cancer initiation, the
simulations start with initially a healthy tissue in a homeostatic re-
gime, defined as the steady state solution to Eqs. S1–4, using the
parameters in the column labeled Normal.
Pathways to Cancer
The basic model describes the acquisition of mutations from three
classes, denoted by R, D, and G , associated with increased rates of
proliferation, decreased rate of death, and increased rate of occur-
rence of mutations, respectively. We considered all six possible orders
in which these mutations may be accumulated and have compared
the dynamics of the resulting mutated populations (N denotes nor-
mal state of a cell, with no mutations).
1. N ⇒ D ⇒ R ⇒ G , 4. N ⇒ R ⇒ G ⇒ D,
2. N ⇒ D ⇒ G ⇒ R, 5. N ⇒ G ⇒ R ⇒ D,
3. N ⇒ R ⇒ D ⇒ G , 6. N ⇒ G ⇒ D ⇒ R;
The model enables us to distinguish between populations of cells
that have acquired the same types of mutations but in a different
order. This key feature allows us to perform a quantitative study of
the dynamics associated with the different sequences of mutations
and their effect on the pace of carcinogenesis. For each of the six se-
quences of mutations, we looked at the emergence and development of
cancer stem cells and cancerous differentiating cells that, by our defi-
nition, have accumulated all three mutations.We found that the size of
each population and its temporal dynamics strongly depend on the
particular order in which the mutations are acquired. The results are
summarized in Figure 3 for parameters listed in Table 1. In Figure 3, A
and B, the number of cancer stem cells and cancer-differentiating
cells is plotted for each mutation sequence as a function of time. It
is interesting to observe how the development of the transformed
stem cell populations correlates and determines the dynamics of the
transformed differentiating population. This shows that our model
supports the hypothesis that the transformed stem cells are critical
mediators of large-scale tumor growth dynamics. It is also apparent
that the location of the G-mutation within the sequence has a critical
effect on the pace of development of the cancerous cell population.
The fastest-emerging tumors are related to sequences of mutations
with the G-mutation being the first acquired mutation, whereas the
slowest pace is associated with sequences in which the G-mutation is
acquired last. Although the G-mutation is not a mutation that is asso-
ciated with increased fitness of cells, it acts as an accelerator toward
acquisition of mutations that increase fitness leading to fast clonal ex-
pansion of the mutated cell population and earlier onset of cancer. The
details of the dynamics of the cancerous population depend on the
relative rates of proliferation and death and on the effect of the R
and D mutations on those rates. However, this striking result, which
is shown for the set of parameters in column labeled Mutated (A) in
Table 1, is robust for a wide range of parameters for both stem cell and
progenitor populations.
It is interesting to note that the first transformed cell (i.e., a cell that
has acquired all three mutations) is a differentiating cell and not a
stem cell; however, owing to the limited proliferative capacity of this
cell, it will not cause tumor formation. Actually, many transformed
cells are present in the tissue at any one time; however, it is the ap-
pearance of a cancer stem cell that leads to continuous tumor growth.
In Figure 3C , we point to the time at which the first cancer stem cell
appears, and in Figure 3D, the time to macroscopic cancerous popu-
lation of 108 cells is shown. The emergence of the first cancer stem cell
corresponds to the onset of a malignancy. Clearly, when G-mutation is
first, there is an early onset of cancer at 14.6 or 17.7 years, whereas if
the G-mutation is last, the first cancer stem cell appears around 80 or
90 years. For the specified set of parameters, only sequences with early
acquisition of the G-mutation will lead to a detectable disease during
the human lifetime, as shown in Figure 3D.
Tissue Composition
As mutated populations emerge and develop, the tissue composi-
tion changes with time. Our model allows for a simple tracking of
these changes, by looking at the sizes of the various populations of
normal and mutated cells at different time points. We have compared
the dynamics of tissue composition for the fastest and slowest se-
quences of mutations ([N ⇒ G ⇒ R ⇒ D] and [N ⇒ D ⇒ R ⇒
G ], respectively), focusing separately on the populations of stem cells
(Figure 4, A and B) and differentiating cells (Figure 4, C and D).
It is apparent that for the slowest sequence, stem cells that have ac-
quired only one mutation are the dominant population and no cancer
stem cell is expected to emerge until approximately 80 to 90 years;
whereas for the fastest sequence, the population of stem cells with
three mutations emerges quickly, resulting in a large number of cancer
stem cells at a much younger age. The dynamics of the differentiating
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populations in both cases reflects the differences in stem cell compo-
sition. For the fastest sequences (Figure 4C ), the population of differ-
entiating cells with all three mutations develops at the fastest pace,
tending to overgrow the other mutated populations with one and two
mutations; whereas for the slowest sequence (Figure 4D), the overall
number of transformed cells is well below detection. So, for example, if
we examine the tissue at 40 years, we will find that for the fastest se-
quence of mutations ([N ⇒ G ⇒ R ⇒ D]), the mutated stem cell
population in the tissue is composed of 86% cells with G mutation,
12% with both G and R mutations and 2% with all three mutations;
whereas in the case of the slowest sequence ([N ⇒ D ⇒ R ⇒ G ]),
mutated stem cells only acquired one mutation and comprise 100%
of the mutated stem cells. The composition of mutated differentiating
cells behaves similarly, and we find that, whereas for the slowest se-
quence, almost 100% of the mutated differentiating cells have only
one mutation, for the fastest sequence, the populations with one,
two, and three mutations comprise 72%, 19%, and 8%, respectively.
Although differences in tissue composition over time between the
fastest and slowest paths are evident, the overall significance of the
mutated populations is small and does not exceed 2% of the total num-
ber of tissue cells (Figure W3 in Supplemental Material). The tissue
has sufficient normal cells to keep functioning, while the emerging
mutated cell populations intrude locally on the healthy balance. In
the case of the slowest sequence, there are no emerging cancer stem
cells during a human lifetime, and the cancerous cells comprise a small
percentage of tissue cells and are spread randomly within the tissue,
without disturbing it significantly. In the case of the fastest sequence
of mutations, where cancer stem cells do emerge, tumors start to de-
velop locally by clonal expansion of these cancer stem cells. Over time,
this excess growth in the tissue may disturb its normal function.
The predictions of the number of cancer cells presented in Fig-
ures 3 and 4, A–D, include all the transformed cells in the tissue,
without considering specific clones of mutated cells. Our results sug-
gest that in the absence of cancer stem cells, the excess of mutated
cells does not lead to a significantly large population of cancer cells
and therefore no noticeable distraction of tissue function is experi-
enced during the period of human lifetime. It is the presence of cancer
stem cells that leads to malignancy. Therefore, the most significant
event in carcinogenesis is the appearance of a cancer stem cell.
Figure 3. G-mutation sets the pace: The transformed stem (A) and differentiating (B) cells2 are plotted as a function of time [Table 1
(Normal and Mutated (A)) for parameters]. The time at which the first cancer stem cell appears (C) and the age at which the population of
transformed cells reaches 108 cells (D) is determined.
2Because we are using a continuous ODE model, the variable that represents the number of cancer
stem cells can take any non-negative real value. The graph continues all the way down to zero in
the y-axis but we have chosen to crop it at 103.
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We have been able to identify the appearance of the first cancer
stem cell and to follow the size of tumor that is developed owing
to this cell of origin. We have isolated the cancerous population that
arises owing to the appearance of the first cancer stem cell for the
fastest mutation sequence [N ⇒ G ⇒ R ⇒ D], Figure 4E . For this
particular sequence, the tumor reaches the maximal size for an avas-
cular tumor (106 cells) shortly after the first cancer cell appears (at
approximately 14.5 years). The cancerous population grows rapidly
initially as the asymmetric division of the cancer stem cell starts a
cascade of divisions in progenitors that divide at a relatively high rate
and therefore produce a large population of cancerous cells in a short
period. When reaching a quasi–steady state, the cancer stem cell con-
tinuously seeds this population, resulting in a slowly growing phase.
This pattern of fast initial growth and slower growth in later stages is
typical to many cancers and is well described by a sigmoid function
[62]. In breast tumors, for example, the growth is described by a par-
ticular case of the sigmoid, referred to as the Gompertzian growth
curve [63–65].
Mutations Effecting Stem Cell Division Pattern
Proliferation in R-mutated stem cells may be affected in two distinct
ways. So far, the case where the R-mutation increases the prolifera-
tion rate without changing the relative proportion of the different di-
vision modes has been investigated. However, because cancer may be
associated with deregulation in self-renewal pathways of stem cells, it
is important to study the effect of the deregulation of the pattern of
self-renewal on cancer initiation. Therefore, we have simulated the
case where the R-mutated stem cells experience a change in their divi-
sion pattern; specifically, a larger proportion of R-mutated stem cells
exhibit symmetric self-renewal rather than asymmetric division [for
parameters, see Table 1, column labeled Mutated (B)]. Our results
suggest that changes in division pattern fatally affects all six sequences
of mutation acquisition, leading to the onset of malignant disease
at early ages, ranging between 6.7 years for the fastest sequence and
15.9 years for the slowest sequence. In Figure 5A, we present the age
of the appearance of the first cancer stem cell for each sequence side by
side with the age of onset of cancer in the case where R mutation only
Figure 4. Tissue composition: The stem cell populations are plotted, as a function of time for (A) the fastest ([N ⇒ G ⇒ R ⇒ D]) and (B) the
slowest ([N ⇒ D ⇒ R ⇒ G ]) mutation sequences. The predictions for the differentiating cells are plotted in (C) and (D). Cancerous cells
resulting from a single transformed stem cell exhibit characteristics of sigmoid growth (E).
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affected the proliferation rate of stem cells. This clearly emphasizes that
the significant speeding of the process of cancer initiation in the case
when the R-mutation affects the division pattern of stem cells di-
minishes the accelerating effect of genetic instability (Figure W5).
Also, when only the rates of stem cell division are affected by the R-
mutation, the number of cancer cells in most sequences does not reach
detectable levels until very old age if at all; however, when the balance
between symmetric self-renewal and asymmetric division is broken, a
rapid outbreak of disease is experienced, and all sequences result in de-
tectable malignancies within 20 years (Figure 5B).
Mutated tissue composition is shown in the graphs in Figure 5,
C–F, where the relative proportions of cells with one (dash), two
(dash-dot), and three (solid) mutations in stem cell and differentiat-
ing populations is displayed for the fastest and the slowest sequences.
Comparison of the population dynamics for the slowest and fastest
sequences shows that, in both cases, the population of cells with one
mutation that comprise the bulk of mutated cells for shorter times
reduces in proportion in favor of population of two mutations and
later the population with three mutations. This shift in the dominat-
ing mutated population occurs sooner for the fastest sequence. We
have been able to compare the dynamics in the case of altered pattern
of division in stem cells to the dynamics of mutated populations in
the case of only increased rate of division (Supplemental Material,
Figure W4). In the latter case, even the fastest sequence leads to a
much slower and smaller rise in the relative proportion of the popu-
lations with two or three mutations. Taken together, these results il-
lustrate that the disturbance of the normal division pattern in stem
cells has fatal consequences on the course of the disease, with or with-
out the presence of genetic instability.
Immortality of Progenitors
Cancer may also develop owing to mutated progenitor cells that
acquire some degree of self-renewal ability and therefore fail to prop-
erly differentiate. We have investigated the effect of this type of ad-
ditional immortality mutation that interrupts the differentiation of
progenitor cells by adding an additional mutation that blocks differ-
entiation of proliferating progenitors, triggering self-renewal rather
than stepping down the lineage.
We have simulated the case in which this mutation may occur
in completely transformed progenitors of second generation (those
that have already accumulated the R, D, and G mutations and have
Figure 5. Modifying the R-mutation: The time of the first cancer stem cell appearance (A, right bars) and the age at which transformed
cells reach 108 (B, right bars) is determined using Mutated (B) parameters (Table 1). The left bars in (A) and (B) are the results shown in
Figure 4, presented here for reference. Mutated stem cell population compositions are plotted as a function of time for (C) the fastest
([N ⇒ G ⇒ R ⇒ D]) and (D) the slowest ([N ⇒ D ⇒ R ⇒ G ]) mutation sequences. The predictions for the population of mutated differen-
tiating cells are plotted in (E) and (F).
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divided twice). The system of equations that we have used for this
case can be found in the Supplemental Material (Eqs. S6–9 with the
appropriate modification given in Eqs. S10a–10c). For parameters,
see Table 1 column Mutated (C).
The result of this mutation is dramatic. In Figure 6, we present the
dynamics of the cancer cell population for the case described above.
The differentiation of these progenitors is then arrested leading to the
rapid emergence of aggressively self-renewing cells that do not ma-
ture. Figure 6 clearly demonstrates that the course of growth in
the cancer population exhibits a steep rise when the immortality mu-
tation is acquired, reaching lethal numbers within weeks. Existence
of cells that acquired this mutation dramatically changes tissue com-
position, now dominated by nondifferentiating early progenitors as
its main component. This mutation that affects committed progeni-
tors rather than stem cells largely overrides the effect of mutations
that induce genetic instability, leading to a lethal burden of mutated
cells that block normal tissue function.
Protection Mechanism
In the simulations so far, mutated cells have not had any survival
restrictions and protection mechanisms have not been considered.
We, therefore, have simulated a possible protection mechanism that
ensures activation of apoptotic triggers in case of the lethal mutations
by increasing the death rate of cells that acquire a mutation other
than the D-mutation. The results are summarized in Figure 7, where
we show both the effect of this protection on the overall dynamics of
carcinogenesis and the particular effect on the appearance of the first
cancer stem cell. Figure 7A presents the dynamics of the population
of cancer stem cells if the mutated cells with mutations other than
D die with rate of 0.1/day (very high compared with the death rates
shown in Table 1). The effect of this type of protection, as seen
in Figure 7, A and B, is the suppression of sequences that have the
D-mutation acquired at later stages. In this case, the order of the G-
mutation has only a secondary significance. In particular, the time of
occurrence of the first cancer stem cell (Figure 7C , right bars), while
left unchanged for the [N ⇒ D ⇒ R ⇒ G ] and the [N ⇒ D ⇒
G ⇒ R] sequences, is lengthened significantly, beyond 100 years of
age for all other sequences, which notably differs from the unsup-
pressed case (shown for reference in Figure 7C , left bars). This pro-
vides evidence that the sequences of mutations for which the cell
cycle checkpoints are not impaired; the mutated cells have a high
probability of undergoing apoptosis, and the onset of cancer is sig-
nificantly delayed.
Discussion
We have presented a general mathematical framework to quanti-
tatively study carcinogenesis. The model captures key features such as
hierarchical tissue structure and maturation of progenitor cells and
includes explicitly all possible division modes of stem cells. The dif-
ferentiation of progenitors in our model occurs through division, and
the dynamics of each progenitor generation can be studied individ-
ually. This feature provides information about the distribution of age
and differentiation within the total population of progenitors and is
particularly useful when studying the effect of mutations that inter-
fere with differentiation and mortality.
We used the model to explore cancer initiation as a multistep pro-
cess of accumulation of somatic mutations within tissue cells. In
particular, we have studied how the order in which mutations are
acquired and the phenotypic alterations in mutated cells affect the
pace of carcinogenesis. The model predicts that the details of cancer
growth dynamics are governed by the specific effect of the mutations
that led to cellular transformation. We have also characterized differ-
ences in the dynamics of the various cellular populations depending
on the particular order of mutations accumulation and on their phys-
iological expression.
In case where the R and D mutations only affect the rates of di-
vision and death of mutated cells, respectively, we have found that
the fastest transformation occurs when the G-mutation is acquired
first, a result that is robust to changes within a wide range of param-
eters. This finding is not surprising, noticing that the effect of the
G -mutation on mutation rates is approximately 100-fold higher than
the effect of the R and D mutations on the replication and death
rates, respectively. These phenotypic expressions that lead to in-
creased fitness in mutated cells have been discussed in former studies.
In this case, the fastest sequence of mutations found in our simula-
tions agrees with the results of Michor et al. for colon cancer [15];
however, it differs from that found by Spencer et al. [16], who con-
sidered mutation acquisition in a homogeneous system of cells. The
reason for this disagreement does not lie in the incorporation of hi-
erarchy in our model but in the fact that Spencer et al. did not track
the particular history of the cells in the various populations, rather
they integrated over all the cells with a particular set of mutations
regardless of the history of the order of acquisition. In this study,
we were able to show that the particular order in which mutations
are accumulated is crucial and that different sequences lead to differ-
ent dynamics governing the emergence of cancerous cells within the
tissue. Therefore, by looking carefully at the various mutation histo-
ries, we observe that the sequence that Spencer et al. determined to
be fastest, [N ⇒ D ⇒ R ⇒ G ], is actually the slowest sequence in
our analysis.
Not only is mutation order important, each one’s specific effect on
proliferation and death is critical as well. Using our model, we have
been able to simulate and analyze the effect of various phenotypic
changes of mutated cells. Recent experiments [51] show that while
the oncogene Bcr-Abl, which is associated with CML, drastically alters
Figure 6. Immortal progenitors: Size of the cancer cell population
is plotted as a function of time for the case where a fourth muta-
tion that leads to immortality of progenitors may be acquired by
early progenitors. Here, the dynamics of the cancer cell population
owing to possible acquisition of this mutation by progenitors of
second generation that only divided twice is plotted.
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the rates of division and death in mutated stem cells, the oncogene
HoxA9-Nup98 (associated with AML) does not affect cell death
or division rates but significantly disturbs the balance between sym-
metric self-renewal and asymmetric division in stem cells. These
experimental results suggest that deregulation of stem cell division
modes is related to more aggressive cancers, and our simulations are
in agreement with these results. Because the model includes the
possible modes of stem cells division, it enabled us to study the
deregulation of the homeostatic division pattern. In fact, we found
that the impact of mutations that led to an increase in symmetric
self-renewal was momentous. These types of mutations diminish
the importance of the G-mutation and result in early cancer initia-
tion and extremely rapid cellular growth.
We have also studied the case where early progenitors may acquire
a certain degree of immortality, a property normally associated with
stem cells. We have found that when progenitors carry a mutation
that enables them to cease progressing in their lineage when they di-
vide and allows them to symmetrically self-renew, similarly to stem
cells, the increase in number of mutated early progenitors is enor-
mous. This is not surprising given that these cells are dividing at
the rate of progenitor cells but without intact mechanisms ensuring
maturation and death. These progenitors do not further differentiate,
therefore this mutation leads to a fast-emerging population of imma-
ture cells that, owing to the relatively high proliferation rate and
arrest of maturation and death, result in a population of mutated
cells that rapidly reaches lethal numbers. Because, as we have shown,
transformed progenitor cells are sporadically present in the tissue
from a very early age, this mutation, even if the last to be acquired,
can lead to fatal outcome early in life. This scenario has been recently
seen experimentally [37], where differentiation blockade of early mu-
tated progenitors has been observed. Emergence of a population of
self-renewing progenitors is believed to result in the fatal transition
between the less aggressive CML and the fatal blast crisis, which is
the aggressive and final stage of the disease.
An additional consequence of the D-mutation may be manifested
in a defective mechanism of telomere shortening, resulting in an in-
crease of the maximal number of divisions the committed progeni-
tors can undergo. By simulating this possibility, we have found that
although failure of progenitors to properly undergo senescence does
not affect the emergence of cancer stem cells, it nonetheless leads to a
massive increase in mutated cells in the tissue. Mutated cell numbers
become comparable with those of the normal tissue cells within a
period of less than 2 weeks owing to the disruption of the highly
controlled balance of cell proliferation and senescence.
Figure 7. Effect of a protection mechanism: The transformed stem (A) and differentiating (B) cells that emerge when the cell cycle
checkpoints are included in the model. The time at which the first cancer stem cell appears (C, right bars) and the age at which the
population of transformed cells reaches 108 cells (D, right bars) is determined. The left bars in (C) and (D) are the results shown in
Figure 4, presented here for reference.
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In the present work, we have studied potential sequences of three
or four somatic mutations that accumulate in cells and lead to cancer.
Each mutation represents a physiological change in the cell that may
be caused by different mutated genes. A recent study in which several
types of breast and colorectal tumors were genetically analyzed [6]
suggests that a larger number of mutations (11 per tumor, on aver-
age) contribute to the neoplastic process. Some of these mutations
are related to adhesion and invasion, properties that are beyond
the scope of the present work. Our model may be easily extended
to study longer sequences of mutations that affect proliferation, dif-
ferentiation, apoptosis, and reliability of cell cycle checkpoints. Here,
we only treated representative mutations to study the effect of each
phenotypic alteration.
The basic linear model presented here does not include neither feed-
backs between the various cell populations nor the influence of the
environment. Recently, researchers were able to demonstrate that
the pattern of division in the stem cell population depends on the par-
ticular microenvironment in which those stem cells reside [49,51]. A
nonlinear model that includes the influence of the stem cell microen-
vironment and the interactions between the various cell compartments
is currently in working progress.
In conclusion, we believe that the proposed mathematical frame-
workmay provide a quantitative insight into the process of carcinogen-
esis. When developing mathematical models, there is always debate
concerning the amount of biological information the model captures
and its level of complexity; often a delicate balance between the two
is achieved. Here, we have presented a simple linear set of equations
that incorporate many key features of mutational acquisition in hier-
archical tissue. Although linear theories have been presented in the
past, none have incorporated both the sequential acquisition of phe-
notype altering mutations and tissue hierarchy at the same time. The
structure of our model is general and flexible so that, as more data be-
come available and key parameters become assessable, greater com-
plexity can easily be incorporated. Future extension of the model
that we are already considering include the nonlinear information as-
sociated with stem cell niches and regulatory signaling between the
various cell types that mediate the rates and patterns of proliferation
and death. We believe that our general framework has the potential
to provide important assistance in understanding cancer dynamics
both in general and in specific malignancies, especially if used in coop-
eration with biological studies.
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Supplemental Material
Model Equations
Normal tissue. Normal tissue is described by a set of N + 2 ordi-
nary differential equations (ODEs), each describing the rate of change
in size of a population of cells. These equations correspond to the bal-
ance equations schematically shown in the article (Eqs. 1 –4). Eq. S1 de-
scribes the rate of change in the size of the stem cell population, denoted
by S(t). The rates of symmetric self-renewal, symmetric differentiation,
and death of stem cells are denoted by αs, αd and δS, respectively.
dS
dt
¼ αsS−αd S−δSS ðS1Þ
Note that the asymmetric self-renewal division, the rate of which is de-
noted by αa, does not affect the number of stem cells and therefore does
not contribute to Eq. S1.
The rate of change in the number of earliest progenitors denoted
by C0 (the direct outcome of stem cell division, considered as gen-
eration 0) is given in Eq. S2. The division and death rates in this
population are denoted by β0 and μ0, respectively.
dC0
dt
¼ 2αd þ αað ÞS− β0 þ μ0ð ÞC0 ðS2Þ
Note that each asymmetric division contributes one progenitor to
C0, whereas symmetric differentiation division contributes two.
The dynamics of the populations of the subsequent generations of
progenitors (n = 1, 2, …, N − 1) is subject to the N − 1 equations,
each has the form of Eq. S3, where N is the number of divisions
required for the cells in a particular tissue to reach maturity. For each
generation of progenitors, the index n denotes the number of divi-
sions the cell has undergone.
dCn
dt
¼ 2βn−1Cn−1− βn þ μnð ÞCn ðS3Þ
The birth and death rates of the nth generation are denoted by βn and μn,
respectively. Finally, the number of mature cells is described by Eq. S4.
dCN
dt
¼ 2βN−1CN−1−μNCN ðS4Þ
We assume that homeostasis is maintained by a constant number of
stem cells (dS/dt = 0), so that the rates of symmetric division modes
and death, if nonzero, should be balanced, i.e., αs = αd + δS. Therefore,
the number of stem cells is constant in time, i.e., S(t) = SH, and we find
that the steady state solution for the number of progenitors and mature
cells in the tissue is given in Eq. S5.
C0 ¼ 2αd þ αaβ0 þ μ0
SH
Cn ¼ 2βn−1βn þ μn
Cn−1 ¼ 2n−1 2αd þ αaβ0 þ μ0
Yn1
i¼1
βi−1
βi þ μi
" #
SH
CN ¼ 2βN−1βN þ μN
CN−1 ¼ 2N−1 2αd þ αaβ0 þ μ0
YN1
i¼1
βi−1
βi þ μi
" #
SH ðS5Þ
These expressions show that the number of progenitor cells in each gen-
eration and the number of mature cells are determined by the number of
stem cells and the rates of division and death of stem cells and the tran-
sient progenitors of preceding generations. The schematic view of our
model for the normal tissue is shown inFigureW1A, and the steady state
solution for one particular choice of parameters, listed inTable 1 column
Normal, is given in Figure W1B. Notice that because we use a con-
tinuous growth model, the resulting numbers of cells are not neces-
sarily integers.
Tissue with normal and mutated cells. Let S , S (1), S (2), and S (3)
denote the size of stem cell populations in the tissue with zero, one,
two, or three mutations, respectively. Mutated divisions in stem cells
are assumed to occur with probability mS , whereas normal divisions
occur at probability 1 − mS . The rates of change in S , S (1), S (2), and
S (3) are governed by Eq. S6.
dS
dt
¼ 1−2mSð ÞαsS−αdS−mSαaS−δSS
dSð1Þ
dt
¼ 2αs þ αað ÞmSS
þ 1−2mS1ð Þαs1Sð1Þ−αd1Sð1Þ−mS1αa1Sð1Þ−δS1Sð1Þ
dSð2Þ
dt
¼ 2αs1 þ αa1ð ÞmS1Sð1Þ
þ 1−2mS2ð Þαs2Sð2Þ−αd2Sð2Þ−mS2αa2Sð2Þ−δS2Sð2Þ
dSð3Þ
dt
¼ 2αs2 þ αa2ð ÞmS2Sð2Þ þ αs3Sð3Þ−αd3Sð3Þ−δS3Sð3Þ ðS6Þ
The rates αsi, αai, αdi, δSi, and mSi
3 stand for the modified rates for
symmetric self-renewal, asymmetric self-renewal, and symmetric dif-
ferentiation divisions rates, death rate, and probability of mutated di-
vision, respectively, where i = 1, 2, 3 denotes the number of mutations
acquired by the stem cells. Notice that in the way the model is set,
mutations are assumed to occur during division and amutated division
results in two mutated daughter cells.
The various populations of maturing cells are distinguishable by the
number of divisions that each cell in the population has undergone
(subscript) and by the number of mutations carried by the cells in the
population (superscript). For example, C0
(1) denotes the number of cells
in the population of progenitors that are derived from stem cells (those
cells have not undergone any divisions yet) and carry one mutation,
whereas Cn
(3) denotes the number of cells in the cancerous progenitor
population (with all three mutations) that has undergone n divisions.
A decrease in a population of progenitorsCn
(i) is assumed to occur solely
through division or death, denoted by βn
(i) and μn
(i), respectively. The
probability of mutated divisions of progenitors is denoted by mC and
in principle can differ from mS . The set of ODEs for the normal (C0)
and mutated (C0
(i)) earliest progenitors is given in Eq. S7.
dC0
dt
¼ 2αd 1−mSð ÞS þ αa 1−mSð ÞS− β0 þ μ0ð ÞC0
dC ð1Þ0
dt
¼ 2αd þ αað ÞmSS
þ 2αd1 þ αa1ð Þ 1−mS1ð ÞSð1Þ− βð1Þ0 þ μð1Þ0
 
C ð1Þ0
3Population variables and rates that do not have i = 1, 2, and 3 added, have to be understood as
quantities that correspond to the normal, nonmutated populations, or rates.
dC ð2Þ0
dt
¼ 2αd1 þ αa1ð ÞmS1Sð1Þ
þ 2αd2 þ αa2ð Þ 1−mS2ð ÞSð2Þ− βð2Þ0 þ μð2Þ0
 
C ð2Þ0
dC ð3Þ0
dt
¼ 2αd2 þ αa2ð ÞmS2Sð2Þ
þ 2αd3 þ αa3ð ÞSð3Þ− βð3Þ0 þ μð3Þ0
 
C ð3Þ0 ðS7Þ
The rate of change in the number of progenitors in the subsequent
N − 1 generations of mutated and normal cells is subject to the N − 1
ODEs (Eq. S8), depending in the number of mutations (Cn— normal,
Cn
(i) — mutated, n = 1,…, N − 1, i = 1, 2, 3).
dCn
dt
¼ 2βn−1 1−mCð ÞCn−1− βn þ μnð ÞCn
dC ð1Þn
dt
¼ 2βn−1mCCn−1 þ 2βð1Þn−1 1−mC1ð ÞC ð1Þn−1− βð1Þn þ μð1Þn
 
C ð1Þn
dC ð2Þn
dt
¼ 2βð1Þn−1mC1C ð1Þn−1 þ 2βð2Þn−1 1−mC2ð ÞC ð2Þn−1− βð2Þn þ μð2Þn
 
C ð2Þn
dC ð3Þn
dt
¼ 2βð2Þn−1mC2C ð2Þn−1 þ 2βð3Þn−1C ð3Þn−1− βð3Þn þ μð3Þn
 
C ð3Þn ðS8Þ
The temporal behavior of the fully mature normal and mutated cells is
given by the set of ODEs in Eq. S9.
dCN
dt
¼ 2βN−1 1−mCð ÞCN−1−μnCn
dC ð1ÞN
dt
¼ 2βN−1mCCN−1 þ 2βð1ÞN−1 1−mC1ð ÞC ð1ÞN−1−μð1ÞN C ð1ÞN
dC ð2ÞN
dt
¼ 2βð1ÞN−1mC1C ð1ÞN−1 þ 2βð2ÞN−1 1−mC2ð ÞC ð2ÞN−1−μð2ÞN C ð2ÞN
dC ð3ÞN
dt
¼ 2βð2ÞN−1mC2C ð2ÞN−1 þ 2βð3ÞN−1C ð3ÞN−1−μð3ÞN C ð3ÞN ðS9Þ
In the present work, we present the results obtained by numerically solv-
ing our model (usingMATLAB stiff ODE solver ode15s) for the param-
eters listed in Table 1. Because in the present work, we are interested in
the initiation of cancer, we assume that initially the tissue is healthy and
sustains a homeostatic regime. Therefore, our simulations have been
started with normal cell compartments only (the steady state solution
of the equations for normal tissue), whereas the mutated cell compart-
ments S (i),Cn
(i) (n = 0,…,N , i = 1, 2, 3) were initially set to zero. This is
not by any means a restriction of the model, and other initial conditions
may be considered as different questions are addressed.
Immortality of progenitors. Here, we consider the mutation that
results in immortality of progenitors, i.e., the progenitors that carry
this mutation undergo self-renewal rather than progression along
their lineage. We have simulated the case in which this mutation
may occur in completely transformed second-generation progenitors
(those that have already accumulated the R, D, and G mutations and
have divided twice). The system of equations that we have used for
this case is given in Eqs. S6–9 with the appropriate modification given
in Eqs. S10a–10c. In this scenario, it is assumed that the second-
generation cancerous progenitors (the number of which is denoted
by C 2
(3)) have a small probability (P = .000001) to become self-
renewing progenitors. The equation that describes the dynamics of
the progenitors in the second generation does not change (Eq. S10a).
The reason is that we assume that mutations occur during divisions;
therefore, only the succeeding generations are affected. The number
of the newly emerging self-renewing progenitors (denoted by CSR
(3))
increases exponentially with doubling time governed by β2
(3), an in-
creased rate of progenitor division. The population dynamics of the
self-renewing progenitors is described by Eq. S10b. The progenitors
that are directly affected by the suppression of differentiation are in
the subsequent generation, and their equation is modified according
to Eq. S10c. All other equations are not changed, but the effect of
suppression propagates down the lineage.
dC ð3Þ2
dt
¼ 2βð2Þ1 mC2C ð2Þ1 þ 2βð3Þ1 C ð3Þ1 − βð3Þ2 þ μð3Þ2
 
C ð3Þ2 ðS10aÞ
dC ð3ÞSR
dt
¼ 2βð3Þ2 PC ð3Þ2 þ βð3Þ2 C ð3Þ2 −μð3Þ2 C ð3Þ2 ðS10bÞ
dC ð3Þ3
dt
¼ 2βð2Þ2 mC2C ð2Þ2
þ 2βð3Þ2 1−Pð ÞC ð3Þ2 − βð3Þ3 þ μð3Þ3
 
C ð3Þ3 ðS10cÞ
Cancer stem cell hypothesis. According to the cancer stem cell hy-
pothesis, only a small population of tumor cells is capable of forming
and maintaining tumors. These tumorigenic cells referred to as cancer
stem cells form a self-renewing population of cells that gives rise to
phenotypically diverse nontumorigenic cells. Our model has been
shown to be compatible with the cancer stem cell hypothesis, indicating
that those are the transformed stem cells rather than the maturing
cells with limited proliferative potential that may give rise to and sus-
tain tumors. We have compared the outcome of the model (Eqs. S6–
9) simulated for two cases: (i) only stem cells have been allowed to
acquire mutations, whereas the differentiating cells could only prop-
agate mutations along their lineage (the mutation rates of the divid-
ing progenitors have been set to zero— i.e., mC = mC1 = mC2 = 0 in
Eqs. S7–9); and (ii) only differentiating cells have been allowed to
mutate, whereas the stem cells are being protected from genetic al-
teration (the mutation rate of stem cells has been set to zero — i.e.,
mS = mS1 = mS2 = 0 in Eq. S6). The results of both simulations are
summarized in Figure W2A, where the sizes of the emerging can-
cerous populations for both scenarios have been plotted as a func-
tion of time. Although the rise in the number of cancerous cells is
initially significantly faster in case (ii), owing to the higher prolif-
eration rate of progenitors compared to the slowly dividing stem
cells, their numbers quickly reach a steady state that is significantly
below detection level. The limited, albeit mutated, proliferation capac-
ity of the mutated progenitors cells is responsible for this limited
expansion. In case (i), however, the number of cancer cells grows
steadily, because the transformed stem cells serve as a never-ending
source of cancerous progeny, the dynamics of which is off equilib-
rium owing to increased proliferation and reduced death rates. This
figure demonstrates how the hierarchical structure of the tissue pre-
vents mutations that occurred downstream in the lineage from ac-
cumulating owing to the limited life span of the mutation carriers.
Transformed stem cells alone, however, are capable of initiating per-
petual growth of cancerous cell populations.
Experimentally, specific markers have been developed to distin-
guish between tumorigenic and nontumorigenic cells in tumors. Al
Hajj et al. [32], for example, identified tumorigenic human breast
cancer cells as CD44+CD24−/lowLineage−. As few as 100 of these cells
formed tumors when transplanted in mice, whereas thousands of
transplanted nontumorigenic cells failed to initiate tumors. Further-
more, not only could the tumorigenic cells be serially passaged, form-
ing new tumors at each transplantation, but also the tumors initiated
by these cells were phenotypically heterogeneous. Figure W2B shows
the result of a simulation of such an experiment. In some mice, a
total of 10 human transformed stem cells, with no progenitors have
been transplanted. In other mice, 350,000 transformed progenitors
with no transformed stem cells have been transplanted. In the first
case, a steady tumor is initiated (the tumor does not grow further
because, in our simulation, we have not allowed further mutations
to occur). In the second case, although initially a high number of
tumor cells have been transplanted, the tumor eventually degenerates
owing to the limited life span of the progenitors and the absence of
any transformed stem cell source. It demonstrates the differences in
growth owing to transplantation of two types of cells: 1) cancerous
stem cells (tumorigenic) and 2) cancerous progenitor cells (nontu-
morigenic). The resulting curves that show the size of the cancer cell
population as a function of time demonstrate that a small number of
transplanted cancer stem cells may initiate and maintain a tumor,
whereas transplantation of a large number of cancerous progenitor
cells, without a cancerous stem cell source, will not result in tumor
development. In this latter case, the cancerous population will com-
pletely degenerate. Therefore, our model is in agreement with this
experiment and others, supporting the cancer stem cell hypothesis. This
result has important consequences for therapy, suggesting that the
driving force in carcinogenesis are the cancer stem cells, and it is this
population that should be targeted during treatment. Leaving cancer-
ous stem cells after treatment will cause recurrence of the disease,
therefore only the elimination of all tumor cancer cells will lead to
successful therapy [37].
Figure W1. Normal tissue: (A) Schematic view of the model. (B) Number of stem cells (solid) and the number of mature cells (dot-dash).
The simulation has started with 900,000 stem cells and no other cells for the set of parameters listed in Table 1; here, the mature cells
population completely reconstitutes after approximately 2 weeks.
Figure W2. The cancer stem cell hypothesis: The size of cancerous cell population is shown in (A) for the case where only stem cells
(solid) or only progenitor cells (dash) are allowed to mutate. Simulation of cell transplant experiment in mice is shown in (B), where a
total of 10 human transformed stem cells (solid) or 350,000 transformed progenitor cells (dash) have been transplanted.
Figure W3. Tissue composition: The respective percentages of the stem cell populations are plotted in (A) for the fastest [N ⇒ G ⇒ R ⇒ D]
and (B) the slowest [N ⇒ D ⇒ R ⇒ G ] mutation sequences. The same plots for differentiating cells are shown in (C) and (D), respectively
[Table 1, columns labeled as Normal and Mutated (A) for parameters]. Detailed views of (A) to (D) are shown in (E) to (H), respectively.
Figure W4.Mutated populations: The respective percentages of the mutated stem cell populations are plotted in (A) for the fastest [N ⇒
G ⇒ R ⇒ D] and (B) the slowest [N ⇒ D ⇒ R ⇒ G ] mutation sequences. The same plots for mutated differentiating cells are shown in (C)
and (D), respectively [Table 1, columns labeled as Normal and Mutated (A) for parameters].
Figure W5. Modifying the R-mutation: The transformed stem (A) and differentiating (B) cells are plotted as a function of time for all six
sequences of mutations, for the case where the R-mutation changes the division pattern in stem cells [Table 1, columns Normal and
Mutated (B) for parameters].
